{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:27:32Z","timestamp":1720657652503},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.reumae.2024.02.013","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T18:01:36Z","timestamp":1720548096000},"page":"287-290","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum leukemia inhibitory factor (LIF) levels in patients with Takayasu's and Giant cell arteritis: A cross-sectional study"],"prefix":"10.1016","volume":"20","author":[{"given":"Rahime","family":"Aksoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahsin Murat","family":"Turgay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recep","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00fc\u00e7teba Enes","family":"Yayla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine","family":"Uslu Yurteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2024.02.013_bib0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.55.7.481","article-title":"Takayasu arteritis: a review","volume":"55","author":"Johnston","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.reumae.2024.02.013_bib0100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/rheumatology\/kei266","article-title":"Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis","volume":"45","author":"Park","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2024.02.013_bib0105","first-page":"10","article-title":"Dev h\u00fccreli (temporal) arterit","volume":"7","author":"Balc\u0131","year":"2015","journal-title":"RAED J"},{"key":"10.1016\/j.reumae.2024.02.013_bib0110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3906\/sag-1804-136","article-title":"Takayasu arteritis: an update","volume":"48","author":"Keser","year":"2018","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.reumae.2024.02.013_bib0115","doi-asserted-by":"crossref","first-page":"621098","DOI":"10.3389\/fimmu.2020.621098","article-title":"Innate and adaptive immunity in giant cell arteritis","volume":"11","author":"Akiyama","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.reumae.2024.02.013_bib0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/ar3358","article-title":"Giant cell arteritis: immune and vascular aging as disease risk factors","volume":"13","author":"Mohan","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2024.02.013_bib0125","doi-asserted-by":"crossref","first-page":"rkz011","DOI":"10.1093\/rap\/rkz011","article-title":"Interleukin-6 does not upregulate pro-inflammatory cytokine expression in an ex vivo model of giant cell arteritis","volume":"3","author":"O\u2019Neill","year":"2019","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.reumae.2024.02.013_bib0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1358863X18802989","article-title":"Pathogenesis of large vessel vasculitis: implications for disease classification and future therapies","volume":"24","author":"Harky","year":"2019","journal-title":"Vasc Med"},{"key":"10.1016\/j.reumae.2024.02.013_bib0135","article-title":"Takayasu arteritis","volume":"265","author":"Russo","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.reumae.2024.02.013_bib0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.autrev.2011.08.001","article-title":"Pathogenesis of Takayasu's arteritis: a 2011 update","volume":"11","author":"Arnaud","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reumae.2024.02.013_bib0145","first-page":"125","article-title":"The multifunctional role of leukaemia inhibitory factor in cutaneous biology","volume":"13","author":"Szepietowski","year":"2004","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.reumae.2024.02.013_bib0150","first-page":"e877","article-title":"The regulation of leukemia inhibitory factor","volume":"2","author":"Yue","year":"2015","journal-title":"Cancer Cell Microenviron"},{"key":"10.1016\/j.reumae.2024.02.013_bib0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2249.1993.tb05942.x","article-title":"High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy","volume":"92","author":"Lecron","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.reumae.2024.02.013_bib0160","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2024.02.013_bib0165","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2024.02.013_bib0170","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/rheumatology\/ket128","article-title":"Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010)","volume":"52","author":"Misra","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2024.02.013_bib0175","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2024.02.013_bib0180","doi-asserted-by":"crossref","first-page":"R272","DOI":"10.1186\/ar4120","article-title":"Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritis","volume":"14","author":"Yilmaz","year":"2012","journal-title":"Arthritis Res Ther"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574324000820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574324000820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T03:05:50Z","timestamp":1720580750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574324000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2173574324000820"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2024.02.013","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum leukemia inhibitory factor (LIF) levels in patients with Takayasu's and Giant cell arteritis: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2024.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}